Somatic mutations in several tumor suppressor genes (such as TP53, p16, and RB), oncogenes (including c-MYC and β-catenin), and other cancer-associated genes (including E-cadherin and cyclin D1) have been observed in HCC. This evidence concerns the gene CDKN2A and hepatocellular carcinoma.